The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishioka, G. Y.
Right arrow Articles by Sette, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishioka, G. Y.
Right arrow Articles by Sette, A.
The Journal of Immunology, 1999, 162: 3915-3925.
Copyright © 1999 by The American Association of Immunologists

Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes1

Glenn Y. Ishioka2, John Fikes, Gary Hermanson, Brian Livingston, Claire Crimi, Mingsheng Qin, Marie- France del Guercio, Carla Oseroff, Carol Dahlberg, Jeff Alexander, Robert W. Chesnut and Alessandro Sette

Epimmune, San Diego, CA 92121

We engineered a multiepitope DNA minigene encoding nine dominant HLA-A2.1- and A11-restricted epitopes from the polymerase, envelope, and core proteins of hepatitis B virus and HIV, together with the PADRE (pan-DR epitope) universal Th cell epitope and an endoplasmic reticulum-translocating signal sequence. Immunization of HLA transgenic mice with this construct resulted in: 1) simultaneous CTL induction against all nine CTL epitopes despite their varying MHC binding affinities; 2) CTL responses that were equivalent in magnitude to those induced against a lipopeptide known be immunogenic in humans; 3) induction of memory CTLs up to 4 mo after a single DNA injection; 4) higher epitope-specific CTL responses than immunization with DNA encoding whole protein; and 5) a correlation between the immunogenicity of DNA-encoded epitopes in vivo and the in vitro responses of specific CTL lines against minigene DNA-transfected target cells. Examination of potential variables in minigene construct design revealed that removal of the PADRE Th cell epitope or the signal sequence, and changing the position of selected epitopes, affected the magnitude and frequency of CTL responses. Our results demonstrate the simultaneous induction of broad CTL responses in vivo against multiple dominant HLA-restricted epitopes using a minigene DNA vaccine and underline the utility of HLA transgenic mice in development and optimization of vaccine constructs for human use.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Dasgupta, J. Bayry, S. Andre, J. D. Dimitrov, S. V. Kaveri, and S. Lacroix-Desmazes
Auditing Protein Therapeutics Management by Professional APCs: Toward Prevention of Immune Responses against Therapeutic Proteins
J. Immunol., August 1, 2008; 181(3): 1609 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. Depla, A. Van der Aa, B. D. Livingston, C. Crimi, K. Allosery, V. De Brabandere, J. Krakover, S. Murthy, M. Huang, S. Power, et al.
Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections
J. Virol., January 1, 2008; 82(1): 435 - 450.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Qian, J. Xie, S. Hong, J. Yang, L. Zhang, X. Han, M. Wang, F. Zhan, J. D. Shaughnessy Jr, J. Epstein, et al.
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma
Blood, September 1, 2007; 110(5): 1587 - 1594.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Scardino, M. Alimandi, P. Correale, S. G. Smith, R. Bei, H. Firat, M. G. Cusi, O. Faure, S. Graf-Dubois, G. Cencioni, et al.
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge
Cancer Res., July 15, 2007; 67(14): 7028 - 7036.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Leslie, D. A. Price, P. Mkhize, K. Bishop, A. Rathod, C. Day, H. Crawford, I. Honeyborne, T. E. Asher, G. Luzzi, et al.
Differential Selection Pressure Exerted on HIV by CTL Targeting Identical Epitopes but Restricted by Distinct HLA Alleles from the Same HLA Supertype
J. Immunol., October 1, 2006; 177(7): 4699 - 4708.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
X. Li, X. Yang, Y. Jiang, and J. Liu
A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice
Int. Immunol., October 1, 2005; 17(10): 1293 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Chen, L. Wang, J. Zhang, L. Zou, Z. Jia, W. Zhou, Y. Wan, and Y. Wu
H-2 Kd-Restricted Hepatitis B Virus-Derived Epitope Whose Specific CD8+ T Lymphocytes Can Produce Gamma Interferon without Cytotoxicity
J. Virol., May 1, 2005; 79(9): 5568 - 5576.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Pinchuk, B. C. Starcher, B. Livingston, A. Tvninnereim, S. Wu, E. Appella, J. Sidney, A. Sette, and B. Wizel
A CD8+ T Cell Heptaepitope Minigene Vaccine Induces Protective Immunity against Chlamydia pneumoniae
J. Immunol., May 1, 2005; 174(9): 5729 - 5739.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. McKinney, R. Skvoretz, B. D. Livingston, C. C. Wilson, M. Anders, R. W. Chesnut, A. Sette, M. Essex, V. Novitsky, and M. J. Newman
Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL
J. Immunol., August 1, 2004; 173(3): 1941 - 1950.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Wang, H. Chen, X. Jiang, M. Zhang, T. Wan, N. Li, X. Zhou, Y. Wu, F. Yang, Y. Yu, et al.
Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein
Blood, July 1, 2004; 104(1): 200 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. C. Wilson, D. McKinney, M. Anders, S. MaWhinney, J. Forster, C. Crimi, S. Southwood, A. Sette, R. Chesnut, M. J. Newman, et al.
Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1
J. Immunol., November 15, 2003; 171(10): 5611 - 5623.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond
Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge
J. Immunol., October 15, 2003; 171(8): 4028 - 4039.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. A. Subbramanian, M. J. Kuroda, W. A. Charini, D. H. Barouch, C. Costantino, S. Santra, J. E. Schmitz, K. L. Martin, M. A. Lifton, D. A. Gorgone, et al.
Magnitude and Diversity of Cytotoxic-T-Lymphocyte Responses Elicited by Multiepitope DNA Vaccination in Rhesus Monkeys
J. Virol., September 15, 2003; 77(18): 10113 - 10118.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. B. Boscardin, S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues
Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection
Infect. Immun., May 1, 2003; 71(5): 2744 - 2757.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Karayiannis
Hepatitis B virus: old, new and future approaches to antiviral treatment
J. Antimicrob. Chemother., April 1, 2003; 51(4): 761 - 785.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. Pancholi, M. Perkus, N. Tricoche, Q. Liu, and A. M. Prince
DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice
J. Virol., December 6, 2002; 77(1): 382 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Saren, S. Pascolo, S. Stevanovic, T. Dumrese, M. Puolakkainen, M. Sarvas, H.-G. Rammensee, and J. M. Vuola
Identification of Chlamydia pneumoniae-Derived Mouse CD8 Epitopes
Infect. Immun., July 1, 2002; 70(7): 3336 - 3343.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Alexander, C. Oseroff, C. Dahlberg, M. Qin, G. Ishioka, M. Beebe, J. Fikes, M. Newman, R. W. Chesnut, P. A. Morton, et al.
A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-{gamma} and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery
J. Immunol., June 15, 2002; 168(12): 6189 - 6198.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Schirmbeck, D. Stober, S. El Kholy, P. Riedl, and J. Reimann
The Immunodominant, Ld-Restricted T Cell Response to Hepatitis B Surface Antigen (HBsAg) Efficiently Suppresses T Cell Priming to Multiple Dd-, Kd-, and Kb-Restricted HBsAg Epitopes
J. Immunol., June 15, 2002; 168(12): 6253 - 6262.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Scardino, D.-A. Gross, P. Alves, J. L. Schultze, S. Graff-Dubois, O. Faure, S. Tourdot, S. Chouaib, L. M. Nadler, F. A. Lemonnier, et al.
HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy
J. Immunol., June 1, 2002; 168(11): 5900 - 5906.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Santra, D. H. Barouch, M. J. Kuroda, J. E. Schmitz, G. R. Krivulka, K. Beaudry, C. I. Lord, M. A. Lifton, L. S. Wyatt, B. Moss, et al.
Prior Vaccination Increases the Epitopic Breadth of the Cytotoxic T-Lymphocyte Response That Evolves in Rhesus Monkeys following a Simian-Human Immunodeficiency Virus Infection
J. Virol., May 13, 2002; 76(12): 6376 - 6381.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. G. Smith, P. M. Patel, J. Porte, P. J. Selby, and A. M. Jackson
Human Dendritic Cells Genetically Engineered to Express a Melanoma Polyepitope DNA Vaccine Induce Multiple Cytotoxic T-Cell Responses
Clin. Cancer Res., December 1, 2001; 7(12): 4253 - 4261.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. Tangri, G. Y. Ishioka, X. Huang, J. Sidney, S. Southwood, J. Fikes, and A. Sette
Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes that Are More Potent and Immunogenic than Wild-Type Peptide
J. Exp. Med., September 17, 2001; 194(6): 833 - 846.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. E. Fujimura, S. S. Kinoshita, V. L. Pereira-Chioccola, and M. M. Rodrigues
DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene
Infect. Immun., September 1, 2001; 69(9): 5477 - 5486.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Velders, S. Weijzen, G. L. Eiben, A. G. Elmishad, P.-M. Kloetzel, T. Higgins, R. B. Ciccarelli, M. Evans, S. Man, L. Smith, et al.
Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine
J. Immunol., May 1, 2001; 166(9): 5366 - 5373.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. H. Barouch, A. Craiu, S. Santra, M. A. Egan, J. E. Schmitz, M. J. Kuroda, T.-M. Fu, J.-H. Nam, L. S. Wyatt, M. A. Lifton, et al.
Elicitation of High-Frequency Cytotoxic T-Lymphocyte Responses against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys
J. Virol., March 1, 2001; 75(5): 2462 - 2467.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
K. Chan, D. J. Lee, A. Schubert, C. M. Tang, B. Crain, S. P. Schoenberger, and M. Corr
The Roles of MHC Class II, CD40, and B7 Costimulation in CTL Induction by Plasmid DNA
J. Immunol., March 1, 2001; 166(5): 3061 - 3066.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Sidney, J. L. Dzuris, M. J. Newman, R. P. Johnson, K. Amitinder, C. M. Walker, E. Appella, B. Mothe, D. I. Watkins, and A. Sette
Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins
J. Immunol., December 1, 2000; 165(11): 6387 - 6399.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Loirat, F. A. Lemonnier, and M.-L. Michel
Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization
J. Immunol., October 15, 2000; 165(8): 4748 - 4755.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Delogu, A. Howard, F. M. Collins, and S. L. Morris
DNA Vaccination against Tuberculosis: Expression of a Ubiquitin-Conjugated Tuberculosis Protein Enhances Antimycobacterial Immunity
Infect. Immun., June 1, 2000; 68(6): 3097 - 3102.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. M. Allen, T. U. Vogel, D. H. Fuller, B. R. Mothe, S. Steffen, J. E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, et al.
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
J. Immunol., May 1, 2000; 164(9): 4968 - 4978.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
J. A. Zaia, J.G. P. Sissons, S. Riddell, D. J. Diamond, M.R. Wills, A.J. Carmichael, M.P. Weekes, M. Gandhi, C. La Rosa, M. Villacres, et al.
Status of Cytomegalovirus Prevention and Treatment in 2000
Hematology, January 1, 2000; 2000(1): 339 - 355.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.